ArticleThe Annals of pharmacotherapy2019

Rituximab Exhibits Altered Pharmacokinetics in Patients With Membranous Nephropathy.

Uma Fogueri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.